Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomi... von Reich, Kristian, MD, Armstrong, April W., MD, MPH, Foley, Peter, MD, Song, Michael, MD, Wasfi, Yasmine, MD, PhD, Randazzo, Bruce, MD, PhD, Li, Shu, PhD, Shen, Y.-K., PhD, Gordon, Kenneth B., MD

Volltext

Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial von Gordon, Kenneth B, Foley, Peter, Krueger, James G, Pinter, Andreas, Reich, Kristian, Vender, Ronald, Vanvoorden, Veerle, Madden, Cynthia, White, Katy, Cioffi, Christopher, Blauvelt, Andrew

Volltext

A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis von Gordon, Kenneth B, Duffin, Kristina Callis, Bissonnette, Robert, Prinz, Jörg C, Wasfi, Yasmine, Li, Shu, Shen, Yaung-Kaung, Szapary, Philippe, Randazzo, Bruce, Reich, Kristian

Volltext

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, pso... von Burmester, Gerd R, Panaccione, Remo, Gordon, Kenneth B, McIlraith, Melissa J, Lacerda, Ana P M

Volltext

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and S... von Papp, Kim, MD, PhD, Reich, Kristian, MD, PhD, Leonardi, Craig L., MD, Kircik, Leon, MD, Chimenti, Sergio, MD, Langley, Richard G.B., MD, Hu, ChiaChi, EdM, MS, Stevens, Randall M., MD, Day, Robert M., PhD, Gordon, Kenneth B., MD, Korman, Neil J., MD, PhD, Griffiths, Christopher E.M., MD, FMedSci

Volltext

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-... von Gordon, Kenneth B, Strober, Bruce, Lebwohl, Mark, Augustin, Matthias, Blauvelt, Andrew, Poulin, Yves, Papp, Kim A, Sofen, Howard, Puig, Lluís, Foley, Peter, Ohtsuki, Mamitaro, Flack, Mary, Geng, Ziqian, Gu, Yihua, Valdes, Joaquin M, Thompson, Elizabeth H Z, Bachelez, Hervé

Volltext

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr ... von Strober, Bruce, Thaçi, Diamant, Sofen, Howard, Kircik, Leon, Gordon, Kenneth B., Foley, Peter, Rich, Phoebe, Paul, Carle, Bagel, Jerry, Colston, Elizabeth, Throup, John, Kundu, Sudeep, Sekaran, Chitra, Linaberry, Misti, Banerjee, Subhashis, Papp, Kim A.

Volltext

Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator... von Reich, Kristian, Papp, Kim A, Blauvelt, Andrew, Langley, Richard G, Armstrong, April, Warren, Richard B, Gordon, Kenneth B, Merola, Joseph F, Okubo, Yukari, Madden, Cynthia, Wang, Maggie, Cioffi, Christopher, Vanvoorden, Veerle, Lebwohl, Mark

Volltext

Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis von Papp, Kim, Gordon, Kenneth, Thaçi, Diamant, Morita, Akimichi, Gooderham, Melinda, Foley, Peter, Girgis, Ihab G, Kundu, Sudeep, Banerjee, Subhashis

Volltext

Clinical meaningfulness of complete skin clearance in psoriasis von Strober, Bruce, MD, PhD, Papp, Kim A., MD, PhD, Lebwohl, Mark, MD, Reich, Kristian, MD, Paul, Carle, MD, PhD, Blauvelt, Andrew, MD, Gordon, Kenneth B., MD, Milmont, Cassandra E., PhD, Viswanathan, Hema N., PhD, Li, Joanne, PhD, Pinto, Lionel, PhD, Harrison, David J., PhD, Kricorian, Greg, MD, Nirula, Ajay, MD, PhD, Klekotka, Paul, MD, PhD

Volltext

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled t... von Leonardi, Craig L, Prof, Kimball, Alexa B, MD, Papp, Kim A, MD, Yeilding, Newman, MD, Guzzo, Cynthia, MD, Wang, Yuhua, PhD, Li, Shu, MS, Dooley, Lisa T, DrPH, Gordon, Kenneth B, Dr

Volltext

Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures von Kathuria, Parul, BA, Gordon, Kenneth B., MD, Silverberg, Jonathan I., MD, PhD, MPH

Volltext

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics von Menter, Alan, Strober, Bruce E., Kaplan, Daniel H., Kivelevitch, Dario, Prater, Elizabeth Farley, Stoff, Benjamin, Armstrong, April W., Connor, Cody, Cordoro, Kelly M., Davis, Dawn M.R., Elewski, Boni E., Gelfand, Joel M., Gordon, Kenneth B., Gottlieb, Alice B., Kavanaugh, Arthur, Kiselica, Matthew, Korman, Neil J., Kroshinsky, Daniela, Lebwohl, Mark, Leonardi, Craig L., Lichten, Jason, Lim, Henry W., Mehta, Nehal N., Paller, Amy S., Parra, Sylvia L., Pathy, Arun L., Rupani, Reena N., Siegel, Michael, Wong, Emily B., Wu, Jashin J., Hariharan, Vidhya, Elmets, Craig A.

Volltext

Ethylene Electrosynthesis via Selective CO2 Reduction: Fundamental Considerations, Strategies, and Challenges von O' Carroll, Thomas, Yang, Xiaoxuan, Gordon, Kenneth J., Fei, Ling, Wu, Gang

Volltext

Sequencing of Targeted Therapy in Psoriasis: Does it Matter? von Boswell, Nicole D., Singla, Shikha, Gordon, Kenneth B.

Volltext

Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-control... von Morita, Akimichi, Strober, Bruce, Burden, A David, Choon, Siew Eng, Anadkat, Milan J, Marrakchi, Slaheddine, Tsai, Tsen-Fang, Gordon, Kenneth B, Thaçi, Diamant, Zheng, Min, Hu, Na, Haeufel, Thomas, Thoma, Christian, Lebwohl, Mark G

Volltext

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities von Elmets, Craig A., Leonardi, Craig L., Davis, Dawn M.R., Gelfand, Joel M., Lichten, Jason, Mehta, Nehal N., Armstrong, April W., Connor, Cody, Cordoro, Kelly M., Elewski, Boni E., Gordon, Kenneth B., Gottlieb, Alice B., Kaplan, Daniel H., Kavanaugh, Arthur, Kivelevitch, Dario, Kiselica, Matthew, Korman, Neil J., Kroshinsky, Daniela, Lebwohl, Mark, Lim, Henry W., Paller, Amy S., Parra, Sylvia L., Pathy, Arun L., Prater, Elizabeth Farley, Rupani, Reena, Siegel, Michael, Stoff, Benjamin, Strober, Bruce E., Wong, Emily B., Wu, Jashin J., Hariharan, Vidhya, Menter, Alan

Volltext

Comparative Effectiveness Studies for Psoriasis—The Methods Matter von Strober, Bruce, Gordon, Kenneth B

Volltext

Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies von Menter, Alan, Gelfand, Joel M., Connor, Cody, Armstrong, April W., Cordoro, Kelly M., Davis, Dawn M.R., Elewski, Boni E., Gordon, Kenneth B., Gottlieb, Alice B., Kaplan, Daniel H., Kavanaugh, Arthur, Kiselica, Matthew, Kivelevitch, Dario, Korman, Neil J., Kroshinsky, Daniela, Lebwohl, Mark, Leonardi, Craig L., Lichten, Jason, Lim, Henry W., Mehta, Nehal N., Paller, Amy S., Parra, Sylvia L., Pathy, Arun L., Prater, Elizabeth Farley, Rahimi, Robert S., Rupani, Reena N., Siegel, Michael, Stoff, Benjamin, Strober, Bruce E., Tapper, Elliot B., Wong, Emily B., Wu, Jashin J., Hariharan, Vidhya, Elmets, Craig A.

Volltext

Deucravacitinib in moderate-to-severe psoriasis von Vu, Alan, Maloney, Victoria, Gordon, Kenneth B

Volltext